Literature DB >> 9573010

Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.

H Chin1, A Arai, H Wakao, R Kamiyama, N Miyasaka, O Miura.   

Abstract

Protein tyrosine phosphorylation plays a crucial role in signaling from the receptor for erythropoietin (Epo), although the Epo receptor (EpoR) lacks the tyrosine kinase domain. We have previously shown that the Jak2 tyrosine kinase couples with the EpoR to transduce a growth signal. In the present study, we demonstrate that Lyn, a Src family tyrosine kinase, physically associates with the EpoR in Epo-dependent hematopoietic cell lines, 32D/EpoR-Wt and F36E. Coexpression experiments in COS7 cells further showed that Lyn induces tyrosine phosphorylation of the EpoR and that both LynA and LynB, alternatively spliced forms of Lyn, bind with the membrane-proximal 91-amino acid region of the EpoR cytoplasmic domain. In vitro binding studies using GST-Lyn fusion proteins further showed that the Src homology (SH)-2 domain of Lyn specifically binds with the tyrosine-phosphorylated EpoR in lysate from Epo-stimulated cells, whereas the tyrosine kinase domain of Lyn binds with the unphosphorylated EpoR. Far-Western blotting and synthetic phosphopeptide competition assays further indicated that the Lyn SH2 domain directly binds to the tyrosine-phosphorylated EpoR, most likely through its interaction with phosphorylated Y-464 or Y-479 in the carboxy-terminal region of the EpoR. In vitro binding studies also demonstrated that the Lyn SH2 domain directly binds to tyrosine-phosphorylated Jak2. In vitro reconstitution experiments in COS7 cells further showed that Lyn induces tyrosine phosphorylation of Stat5, mainly on Y-694, and activates the DNA-binding and transcription-activating abilities of Stat5. In agreement with this, Lyn enhanced the Stat5-dependent transcriptional activation when overexpressed in 32D/EpoR-Wt cells. In addition, Lyn was demonstrated to phosphorylate the EpoR and Stat5 on tyrosines in vitro. These results suggest that Lyn may play a role in activation of the Jak2/Stat5 and other signaling pathways by the EpoR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573010

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.

Authors:  K Nishigaki; C Hanson; T Ohashi; D Thompson; K Muszynski; S Ruscetti
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Lyn kinase promotes erythroblast expansion and late-stage development.

Authors:  Vinit G Karur; Clifford A Lowell; Peter Besmer; Valter Agosti; Don M Wojchowski
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

3.  Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis.

Authors:  Yusuke Takeda; Chiaki Nakaseko; Hiroaki Tanaka; Masahiro Takeuchi; Makiko Yui; Atsunori Saraya; Satoru Miyagi; Changshan Wang; Satomi Tanaka; Chikako Ohwada; Emiko Sakaida; Naoto Yamaguchi; Koutaro Yokote; Lothar Hennighausen; Atsushi Iwama
Journal:  Br J Haematol       Date:  2011-04-15       Impact factor: 6.998

4.  Deficiency of Src family kinases compromises the repopulating ability of hematopoietic stem cells.

Authors:  Christie M Orschell; Jovencio Borneo; Veerendra Munugalavadla; Peilin Ma; Emily Sims; Baskar Ramdas; Mervin C Yoder; Reuben Kapur
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

5.  The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.

Authors:  Agata Klejman; Steven J Schreiner; Malgorzata Nieborowska-Skorska; Artur Slupianek; Matthew Wilson; Thomas E Smithgall; Tomasz Skorski
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

6.  The interaction of LCK and the CD4 co-receptor alters the dose response of T-cells to interleukin-7.

Authors:  Christina Kittipatarin; Nuska Tschammer; Annette R Khaled
Journal:  Immunol Lett       Date:  2010-04-28       Impact factor: 3.685

7.  STAT5: a Target of Antagonism by Neurotropic Flaviviruses.

Authors:  Matthew G Zimmerman; James R Bowen; Circe E McDonald; Ellen Young; Ralph S Baric; Bali Pulendran; Mehul S Suthar
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

8.  Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.

Authors:  Matthew A Held; Emily Greenfest-Allen; Su Su; Christian J Stoeckert; Matthew P Stokes; Don M Wojchowski
Journal:  Cell Signal       Date:  2020-02-03       Impact factor: 4.315

9.  The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis.

Authors:  H Zang; K Sato; H Nakajima; C McKay; P A Ney; J N Ihle
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

10.  Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinase.

Authors:  Olivier Kosmider; Dorothée Buet; Isabelle Gallais; Nicole Denis; Françoise Moreau-Gachelin
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.